Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Hirshfield · SciRah

Researcher profile · Semantic Scholar

K. Hirshfield

Share profile

K. Hirshfield — researcher profile on SciRah

h-index: 27
Works: 125
Citations: 3,133

Most-cited papers

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.
J. Mehnert, A. Panda, H. Zhong, K. Hirshfield +15 more
2016Journal of Clinical Investigation356 citations Open access
Semantic Scholar
Abstract C151: Contribution of serine, folate, and glycine metabolism to the ATP, NADPH, and purine requirements of cancer cells.
Philip M. Tedeschi, E. Markert, M. Gounder, Hongxia Lin +8 more
2013243 citations
Semantic Scholar
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
Verónica Rojas, K. Hirshfield, S. Ganesan, L. Rodriguez-Rodriguez
2016International Journal of Molecular Sciences231 citations Open access
Semantic Scholar
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
A. Panda, J. Mehnert, K. Hirshfield, G. Riedlinger +18 more
2018Journal of the National Cancer Institute191 citations Open access
Semantic Scholar
The metabolic demands of cancer cells are coupled to their size and protein synthesis rates
S. Dolfi, L. Chan, Jean Qiu, Philip M. Tedeschi +4 more
2013Cancer & Metabolism173 citations Open access
Semantic Scholar
RET rearrangements are actionable alterations in breast cancer
Bhavna S. Paratala, J. Chung, C. Williams, B. Yilmazel +18 more
2018Nature Communications117 citations Open access
Semantic Scholar
Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients
S. Tian, K. Hirshfield, S. Jabbour, D. Toppmeyer +3 more
2014Frontiers in Oncology94 citations Open access
Semantic Scholar
Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.
E. Severson, G. Riedlinger, Caitlin F. Connelly, J. Vergilio +14 more
2018Blood90 citations Open access
Semantic Scholar
Impact of Preexisting Mental Illness on All-Cause and Breast Cancer-Specific Mortality in Elderly Patients With Breast Cancer.
K. Iglay, M. Santorelli, K. Hirshfield, Jill M. Williams +3 more
2017Journal of Clinical Oncology81 citations Open access
Semantic Scholar
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers
K. Hirshfield, Denis Tolkunov, H. Zhong, Siraj M. Ali +26 more
2016The Oncologist80 citations Open access
Semantic Scholar
Diagnosis and treatment delays among elderly breast cancer patients with pre-existing mental illness
K. Iglay, M. Santorelli, K. Hirshfield, Jill M. Williams +3 more
2017Breast Cancer Research and Treatment65 citations
Semantic Scholar
BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAFV600E Mutant Melanoma
A. Kulkarni, H. Al-hraishawi, Srilatha R. Simhadri, K. Hirshfield +10 more
2017Clinical Cancer Research53 citations
Semantic Scholar
Comprehensive genomic profiling of malignant phyllodes tumors of the breast
S. Nozad, Christine E. Sheehan, L. Gay, J. Elvin +12 more
2017Breast Cancer Research and Treatment53 citations
Semantic Scholar
A functionally significant SNP in TP53 and breast cancer risk in African-American women
M. Murphy, Song Liu, S. Yao, D. Huo +29 more
2017npj Breast Cancer49 citations Open access
Semantic Scholar
Triple-negative breast cancer: molecular subtypes and targeted therapy
K. Hirshfield, S. Ganesan
2014Current Opinion in Obstetrics and Gynecology42 citations
Semantic Scholar
Roadmap to a Comprehensive Clinical Data Warehouse for Precision Medicine Applications in Oncology
D. Foran, Wen-Jin Chen, Huiqi Chu, Evita T. Sadimin +7 more
2017Cancer Informatics39 citations Open access
Semantic Scholar
Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers
L. Rodriguez-Rodriguez, K. Hirshfield, Verónica Rojas, R. DiPaola +10 more
2016Gynecologic Oncology38 citations Open access
Semantic Scholar
Role of Biomarkers in the Development of PARP Inhibitors
Bratati Ganguly, S. Dolfi, L. Rodriguez-Rodriguez, S. Ganesan +1 more
2016Biomarkers in Cancer37 citations Open access
Semantic Scholar
Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs
S. Dolfi, A. Jäger, D. Medina, B. Haffty +2 more
2014Cancer Letters35 citations Open access
Semantic Scholar
Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells
Jessica L. F. Teh, Raj Shah, Stephanie N. La Cava, S. Dolfi +8 more
2015Breast Cancer Research and Treatment33 citations Open access
Semantic Scholar
Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing Data
Hossein Khiabanian, K. Hirshfield, Mendel Goldfinger, S. Bird +15 more
2018JCO Precision Oncology25 citations Open access
Semantic Scholar
Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells
S. Dolfi, D. Medina, A. Kareddula, Bhavna S. Paratala +7 more
2017OncoTarget25 citations Open access
Semantic Scholar
Effects of breast cancer on chronic disease medication adherence among older women
M. Santorelli, M. Steinberg, K. Hirshfield, G. Rhoads +3 more
2016Pharmacoepidemiology and Drug Safety23 citations
Semantic Scholar
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States
J. Sieluk, Yan Song, J. Freimark, Min Huang +5 more
2021Advances in Therapy22 citations
Semantic Scholar
Associations between sociodemographic and clinicopathological factors, and breast cancer subtypes in a population-based study
A. Llanos, S. Chandwani, E. Bandera, K. Hirshfield +3 more
2015Cancer Causes and Control22 citations Open access
Semantic Scholar
KEYNOTE-756: Randomized, double-blind, phase 3 study of pembrolizumab vs placebo combined with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk, early-stage estrogen receptor–positive, human epidermal growth factor receptor 2–negative (ER+/HER2−) breast cancer.
F. Cardoso, A. Bardia, F. André, D. Cescon +11 more
2019Journal of Clinical Oncology21 citations
Semantic Scholar
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
E. Gorshein, Kant M. Matsuda, G. Riedlinger, L. Sokol +9 more
2021Case Reports in Oncology19 citations Open access
Semantic Scholar
Targetable alterations in invasive pleomorphic lobular carcinoma of the breast
G. Riedlinger, S. Joshi, K. Hirshfield, N. Barnard +1 more
2020Breast Cancer Research19 citations Open access
Semantic Scholar
Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers
Bhavna S. Paratala, S. Dolfi, Hossein Khiabanian, L. Rodriguez-Rodriguez +2 more
2016Biomarkers in Cancer19 citations Open access
Semantic Scholar
Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women.
M. Santorelli, K. Hirshfield, M. Steinberg, G. Rhoads +2 more
2016Annals of Epidemiology19 citations
Semantic Scholar
Robust Automatic Breast Cancer Staging Using A Combination of Functional Genomics and Image-Omics
Hai Su, Yong Shen, Fuyong Xing, X. Qi +3 more
2015Annual International Conference of the IEEE Engineering in Medicine and Biology Society16 citations Open access
Semantic Scholar
Activated matriptase as a target to treat breast cancer with a drug conjugate
G. Rather, Siang-Yo Lin, Hongxia Lin, Whitney A. Banach-Petrosky +5 more
2018OncoTarget13 citations Open access
Semantic Scholar
Exploring open-label bias in patient-reported outcome (PRO) emotional domain scores in cancer trials.
P. Chakravarti, E. Basch, K. Hirshfield, B. King-Kallimanis +5 more
201812 citations
Semantic Scholar
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
F. Cardoso, K. Hirshfield, Kimberly A Kraynyak, K. Tryfonidis +1 more
2024npj Breast Cancer11 citations
Semantic Scholar
DTIE, a novel core promoter element that directs start site selection in TATA-less genes
Nadav Marbach-Bar, A. Bahat, Shaked Ashkenazi, Michal Golan-Mashiach +7 more
2015Nucleic Acids Research11 citations Open access
Semantic Scholar
Response to Crizotinib in a Patient with MET-mutant Papillary Renal Cell Cancer After Progression on Tivantinib
M. Stein, K. Hirshfield, H. Zhong, E. Singer +2 more
2014European Urology11 citations Open access
Semantic Scholar
Racial differences in the effects of comorbidity on breast cancer-specific survival
M. Santorelli, K. Hirshfield, M. Steinberg, Yong Lin +3 more
2017Cancer Causes and Control10 citations
Semantic Scholar
Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma Sharing the PCM1-JAK2 Fusion and a Common T-Cell Clone
G. Riedlinger, Aleksander L. Chojecki, H. Aviv, D. Weissmann +4 more
2019JCO Precision Oncology8 citations Open access
Semantic Scholar
Early triple-negative breast cancer in women aged ≥65: retrospective study of outcomes, resource use and costs, 2010-2016.
J. Sieluk, A. Haiderali, Min Huang, Ling-Feng Yang +1 more
2020Future Oncology6 citations
Semantic Scholar
Factors Associated with Initial Mode of Breast Cancer Detection among Black Women in the Women's Circle of Health Study
Holly Szukis, B. Qin, Cathleen Y Xing, Michelle Doose +9 more
2019Journal of Oncology6 citations Open access
Semantic Scholar
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
Philip M. Tedeschi, E. Markert, M. Gounder, Hongxia Lin +10 more
2013Cell Death and Disease6 citations Open access
Semantic Scholar
The role of chromodomain helicase DNA binding protein 1 (CHD1) in promoting an invasive prostate cancer phenotype
A. Kareddula, D. Medina, Whitney Petrosky, S. Dolfi +7 more
2021Therapeutic Advances in Urology5 citations Open access
Semantic Scholar
Peer Review #3 of "Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods (v0.2)"
Jie Liu, Miao Zhou, Yang-Yang Ouyang, L. Du +249 more
20205 citations Open access
Semantic Scholar
The metabolic demands of cancer cells are coupled to their size and protein synthesis rates
S. Dolfi, L. Chan, Jean Qiu, Philip M. Tedeschi +4 more
2013Cancer & Metabolism5 citations Open access
Semantic Scholar
433TiP Phase III, randomized, open-label TroFuse-010 Study of sacituzumab tirumotecan (sac-TMT) alone and with pembrolizumab vs treatment of physician’s choice chemotherapy (TPC) in patients with HR+/HER2- unresectable locally advanced or metastatic breast cancer (mBC)
S. Tolaney, P. D'Amico, L. Jia, K. Hirshfield +1 more
2024Annals of Oncology4 citations
Semantic Scholar
Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years.
J. Sieluk, Ling-Feng Yang, A. Haiderali, Min Huang +1 more
2021Future Oncology4 citations
Semantic Scholar
Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer
Jatinder Dhami, K. Hirshfield, S. Ganesan, M. Hellmann +8 more
2018Cold Spring Harbor molecular case studies4 citations Open access
Semantic Scholar
KEYNOTE-756: A randomized, double-blind, phase III study of pembrolizumab or placebo with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk, early-stage, ER+/HER2−breast cancer
Fatima Cardoso, A. Bardia, F. André, D. Cescon +11 more
2019Annals of Oncology3 citations Open access
Semantic Scholar
Targeted treatment of RAI-resistant metastatic thyroid cancer postcomprehensive genomic profiling.
K. Hirshfield, J. Aisner, Siraj M. Ali, P. Stephens +3 more
20143 citations
Semantic Scholar
Abstract 4261: Prospective next generation sequencing (NGS) of rare or poor prognosis cancers
K. Hirshfield, Siraj M. Ali, V. Miller, P. Stephens +4 more
20143 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Ganesan×23
Invite
S. Ganesan — researcher profile on SciRah
L. Rodriguez-Rodriguez×14
Invite
L. Rodriguez-Rodriguez — researcher profile on SciRah
Siraj M. Ali×13
Invite
Siraj M. Ali — researcher profile on SciRah
S. Dolfi×12
Invite
S. Dolfi — researcher profile on SciRah

×9

Invite

G. Riedlinger — researcher profile on SciRah

Invite

K. Demissie — researcher profile on SciRah

Invite

Yong Lin — researcher profile on SciRah

Invite

R. DiPaola — researcher profile on SciRah

Invite

J. Bertino — researcher profile on SciRah

Invite

L. Sokol — researcher profile on SciRah

Invite

J. Ross — researcher profile on SciRah

Invite

V. Miller — researcher profile on SciRah